Repligen (RGEN) Gains from Sales and Divestitures (2017 - 2026)
Repligen (RGEN) reported Gains from Sales and Divestitures of $116798.0 for Q1 2026, up 14.69% year-over-year from $101837.0 in Q1 2025, and down 25.18% on a QoQ basis from $156115.0 in Q4 2025.
Repligen (RGEN) has 8 years of Gains from Sales and Divestitures data on file, last reported at $116798.0 in Q1 2026.
- Quarterly Gains from Sales and Divestitures rose 14.69% year-over-year to $116798.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $116798.0 (up 14.69% YoY) and the FY2025 annual result came in at $156115.0, up 5.18% from the prior year.
- Gains from Sales and Divestitures declined to $116798.0 in Q1 2026 per RGEN's latest filing, from $156115.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $208531.0 in Q4 2022 and bottomed at $98246.0 in Q1 2024.
- The 5-year median for Gains from Sales and Divestitures is $139681.0 (2025), against an average of $147172.4.
- The widest annual swing landed in 2024, when Gains from Sales and Divestitures declined 24.14%; it then climbed 14.69% in 2026.
- Tracing RGEN's Gains from Sales and Divestitures over 5 years: stood at $208531.0 in 2022, then slipped by 6.17% to $195672.0 in 2023, then decreased by 24.14% to $148429.0 in 2024, then increased by 5.18% to $156115.0 in 2025, then dropped by 25.18% to $116798.0 in 2026.
- Per Business Quant, the three latest RGEN Gains from Sales and Divestitures figures stand at $116798.0 (Q1 2026), $156115.0 (Q4 2025), and $139681.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116,798.00 |
| Mar 31, 2026 | 116,798.00 |
| Dec 31, 2025 | 156,115.00 |
| Dec 31, 2025 | 156,115.00 |
| Sep 30, 2025 | 139,681.00 |
| Sep 30, 2025 | 139,681.00 |
| Jun 30, 2025 | 122,517.00 |
| Jun 30, 2025 | 122,517.00 |
| Mar 31, 2025 | 101,837.00 |
| Mar 31, 2025 | 101,837.00 |
| Dec 31, 2024 | 148,429.00 |
| Dec 31, 2024 | 148,429.00 |
| Sep 30, 2024 | 137,072.00 |
| Sep 30, 2024 | 137,072.00 |
| Jun 30, 2024 | 125,820.00 |
| Jun 30, 2024 | 125,820.00 |
| Mar 31, 2024 | 98,246.00 |
| Mar 31, 2024 | 98,246.00 |
| Dec 31, 2023 | 195,672.00 |
| Dec 31, 2023 | 195,672.00 |
| Sep 30, 2023 | 173,714.00 |
| Sep 30, 2023 | 173,714.00 |
| Jun 30, 2023 | 156,784.00 |
| Jun 30, 2023 | 156,784.00 |
| Mar 31, 2023 | 123,938.00 |
| Mar 31, 2023 | 123,938.00 |
| Dec 31, 2022 | 208,531.00 |
| Dec 31, 2022 | 208,531.00 |
| Sep 30, 2022 | 190,152.00 |
| Sep 30, 2022 | 190,152.00 |
| Jun 30, 2022 | 175,647.00 |
| Jun 30, 2022 | 175,647.00 |
| Mar 31, 2022 | 130,978.00 |
| Mar 31, 2022 | 130,978.00 |
| Dec 31, 2021 | 212,329.00 |
| Dec 31, 2021 | 212,329.00 |
| Sep 30, 2021 | 185,922.00 |
| Sep 30, 2021 | 185,922.00 |
| Sep 30, 2018 | 134,590.00 |
| Sep 30, 2018 | 134,590.00 |
| Jun 30, 2018 | 115,295.00 |
| Jun 30, 2018 | 115,295.00 |
| Dec 31, 2017 | 114,690.00 |
| Dec 31, 2017 | 114,690.00 |